Examkin

Question

Difficulty: MediumPediatric Cardiovascular Disorders

A 4-year-old boy is admitted to the hospital with a 7-day history of persistent fever measuring up to 39.5°C (103.1°F). Physical examination reveals bilateral bulbar conjunctival injection without exudate, brightly erythematous and cracked lips, a prominent 'strawberry' tongue, erythema and edema of the palms and soles, and a 2.5-cm right-sided cervical lymph node. A diagnosis of Kawasaki disease is made. Arrange the following therapeutic and follow-up steps in the most appropriate chronological order for the optimal management of this patient, from initial hospitalization to long-term preventive care.

  1. 1Administer intravenous immunoglobulin (IVIG) and high-dose aspirin.
  2. 2Transition from high-dose to low-dose aspirin therapy.
  3. 3Perform follow-up transthoracic echocardiography to assess for delayed coronary aneurysms.
  4. 4Administer the live-attenuated measles, mumps, and rubella (MMR) vaccine.

Answer

The correct sequence is to first administer IVIG and high-dose aspirin, then transition to low-dose aspirin after 48 hours of defervescence, subsequently perform follow-up echocardiography at 2 to 6 weeks, and finally administer live-attenuated vaccines at least 11 months post-IVIG.
The natural history and treatment protocol for Kawasaki disease dictates a strict chronological timeline: acute intervention to stop vasculitis (IVIG + high-dose aspirin), subacute management to prevent clotting while avoiding toxicity (low-dose aspirin after 48 hours of defervescence), monitoring for the most feared complication at its peak incidence period (echocardiogram at 2-6 weeks), and addressing the long-term immunological consequence of the initial therapy (delaying live vaccines for 11 months).

Step-by-Step Solution

1
Identify the diagnosis and determine the initial acute intervention.
The patient meets the clinical criteria for Kawasaki disease. The immediate treatment is intravenous immunoglobulin (IVIG) and high-dose aspirin.
Prompt administration within the first 10 days of fever is essential to reduce systemic vasculitis and prevent coronary artery aneurysms.
2
Determine the criteria for tapering acute medical therapy.
Transition to low-dose aspirin once the patient has been afebrile for at least 48 hours.
High-dose aspirin treats inflammation, but carries a risk of toxicity. Once the fever breaks, a low dose is sufficient to prevent platelet aggregation and thrombosis.
3
Establish the schedule for cardiovascular complication surveillance.
Perform a follow-up echocardiogram at 2 and 6 weeks after illness onset.
While a baseline echocardiogram is obtained at diagnosis, coronary changes often take weeks to manifest, making serial imaging critical.
4
Identify necessary adjustments to routine pediatric preventive care.
Delay live-attenuated vaccines (like MMR or varicella) for at least 11 months.
IVIG contains a vast pool of donor IgG antibodies that will neutralize live viral antigens, rendering the vaccine ineffective if given too early.

Key Concept

Management of Kawasaki disease involves sequential progression from acute inflammatory suppression (IVIG and high-dose aspirin) to subacute thrombosis prevention (low-dose aspirin), followed by delayed complication screening (follow-up echocardiography), and finally long-term adjustments to preventive care (delaying live vaccines).
Estimated Time:1m 15s
Rate this question

Topics

Pediatric Cardiovascular Disorders

More questions from this topic